Registro:

Referencias:

• Brener, Z., Biology of Trypanosoma cruzi (1973) Annu. Rev. Microbiol., 27, pp. 347-382
• Cheng, F., Oldfield, E., Inhibition of isoprene biosynthesis pathway enzymes by phosphonates, bisphosphonates, and diphosphates (2004) J. Med. Chem., 47, pp. 5149-5158
• Ciosek Jr., C.P., Lipophilic 1,1-bisphosphonates are potent squalene synthase inhibitors and orally active cholesterol lowering agents in vivo (1993) J. Biol. Chem., 268, pp. 24832-24837
• Coxon, F.P., Thompson, K., Rogers, M.J., Recent advances in understanding the mechanism of action of bisphosphonates (2006) Current Opinion in Pharmacology, 6 (3), pp. 307-312. , DOI 10.1016/j.coph.2006.03.005, PII S1471489206000610, Respiratory/Musculoskeletal
• Docampo, R., Moreno, S.N.J., The acidocalcisome as a target for chemotherapeutic agents in protozoan parasites (2008) Current Pharmaceutical Design, 14 (9), pp. 882-888. , http://www.ingentaconnect.com/content/ben/cpd/2008/00000014/00000009/ art00007, DOI 10.2174/138161208784041079
• Dunford, J.E., Thompson, K., Coxon, F.P., Luckman, S.P., Hahn, F.M., Poulter, C.D., Ebetino, F.H., Rogers, M.J., Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates (2001) Journal of Pharmacology and Experimental Therapeutics, 296 (2), pp. 235-242
• Ferella, M., A solanesyl-diphosphate synthase localizes in glycosomes of Trypanosoma cruzi (2006) J. Biol. Chem., 281, pp. 39339-39348
• Fleisch, H., Russell, R.G.G., Straumann, F., Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis (1966) Nature, 212, pp. 901-903
• Fleisch, H., Russell, R.G.G., Francis, M.D., Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo (1969) Science, 165, pp. 1262-1264
• Francis, M.D., Russell, R.G.G., Fleisch, H., Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo (1969) Science, 165, pp. 1264-1266
• Galel, S.A., Kirchhoff, L.V., Risk factors for Trypanosoma cruzi infection in California blood donors (1996) Transfusion, 36 (3), pp. 227-231
• Hosfield, D.J., Zhang, Y., Dougan, D.R., Broun, A., Tari, L.W., Swanson, R.V., Finn, J., Structural Basis for Bisphosphonate-mediated Inhibition of Isoprenoid Biosynthesis (2004) Journal of Biological Chemistry, 279 (10), pp. 8526-8529. , DOI 10.1074/jbc.C300511200
• Kavanagh, K.L., The molecular mechanism of nitrogencontaining bisphosphonates as antiosteoporosis drugs (2006) Proc. Natl. Acad. Sci. U. S. A., 103, pp. 7829-7834
• Kirchhoff, L.V., Current concepts: American trypanosomiasis (Chagas' disease) - A tropical disease now in the United States (1993) New England Journal of Medicine, 329 (9), pp. 639-644. , DOI 10.1056/NEJM199308263290909
• Lawrence, R.M., Enantioselective synthesis of α-phosphono sulfonate squalene synthase inhibitors: Chiral recognition in the interactions of an α-phosphono sulfonate inhibitor with squalene synthase (1996) J. Am. Chem. Soc., 118, pp. 11668-11669
• Liñares, G.E., Ravaschino, E.L., Rodriguez, J.B., Progresses in the field of drug design to combat tropical protozoan parasitic diseases (2006) Curr. Med. Chem., 13, pp. 335-360
• Ling, Y., Sahota, G., Odeh, S., Chan, J.M.W., Araujo, F.G., Moreno, S.N.J., Oldfield, E., Bisphosphonate inhibitors of Toxoplasma gondi growth: In vitro, QSAR, and in vivo investigations (2005) Journal of Medicinal Chemistry, 48 (9), pp. 3130-3140. , DOI 10.1021/jm040132t
• Magnin, D.R., 1,1-Bisphosphonate squalene synthase inhibitors: Interplay between the isoprenoid subunit and the diphosphate surrogate (1995) J. Med. Chem., 38, pp. 2596-2605
• Magnin, D.R., α-Phosphonosulfonic acids: Potent and selective inhibitors of squalene synthase (1996) J. Med. Chem., 39, pp. 657-660
• Martin, M.B., Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: A potential route to chemotherapy (2001) J. Med. Chem., 44, pp. 909-916
• McTaggart, F., Inhibition of squalene synthase of rat liver by novel 3= substituted quimuclidines (1996) Biochem. Pharmacol., 51, pp. 1477-1487
• Oldfield, E., Targeting isoprenoid biosynthesis for drug discovery: Bench to bedside (2010) Acc. Chem. Res., 43, pp. 1216-1226
• Poulter, C.D., Biosynthesis of non-head-to-tail terpenes. Formation of 1′-1 and 1′-3 linkages (1990) Acc. Chem. Res., 23, pp. 70-77
• Reszka, A.A., Rodan, G.A., Nitrogen-containing bisphosphonate mechanism of action (2004) Mini-Reviews in Medicinal Chemistry, 4 (7), pp. 711-719
• Reszka, A.A., Rodan, G.A., Mechanism of action of bisphosphonates (2003) Curr. Osteoporos. Rep., 1, pp. 45-52
• Rogers, M.J., Frith, J.C., Luckman, S.P., Coxon, F.P., Benford, H.L., Monkkonen, J., Auriola, S., Russell, R.G.G., Molecular mechanisms of action of bisphosphonates (1999) Bone, 24 (5 SUPPL.), pp. 73S-79S. , DOI 10.1016/S8756-3282(99)00070-8, PII S8756328299000708
• Roelofs, A.J., Thompson, K., Ebetino, F.H., Rogers, M.J., Coxon, F.P., Bisphosphonates: Molecular mechanisms of action and effects on bone cells, monocytes and macrophages (2010) Curr. Pharm. Des., 16, pp. 2950-2960
• Rondeau, J.-M., Bitsch, F., Bourgier, E., Geiser, M., Hemmig, R., Kroemer, M., Lehmann, S., Jahnke, W., Structural basis for the exceptional in vivo efficacy of bisphosphonate drugs (2006) ChemMedChem, 1 (2), pp. 267-273. , DOI 10.1002/cmdc.200500059
• Rosso, V.S., Synthesis and biological evaluation of New 2-alkylaminoethyl-1,1- bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii targeting farnesyl diphosphate synthase (2011) Bioorg. Med. Chem., 19, pp. 2211-2217
• Russell, R.G.G., Rogers, M.J., Bisphosphonates: From the laboratory to the clinic and back again (1999) Bone, 25 (1), pp. 97-106. , DOI 10.1016/S8756-3282(99)00116-7, PII S8756328299001167
• Sealey-Cardona, M., Cammerer, S., Jones, S., Ruiz-Perez, L.M., Brun, R., Gilbert, I.H., Urbina, J.A., Gonzalez-Pacanowska, D., Kinetic characterization of squalene synthase from Trypanosoma cruzi: Selective inhibition by quinuclidine derivatives (2007) Antimicrobial Agents and Chemotherapy, 51 (6), pp. 2123-2129. , DOI 10.1128/AAC.01454-06
• Szajnman, S.H., Design, synthesis and biological evaluation of 1-(fluoroalkylidene)-1,1- bisphosphonic acids against Toxoplasma gondii targeting farnesyl diphosphate synthase (2012) Org. Biomol. Chem., 10, pp. 1424-1433
• Szajnman, S.H., Garcia, L.G.E., Li, Z.-H., Jiang, C., Galizzi, M., Bontempi, E.J., Ferella, M., Rodriguez, J.B., Synthesis and biological evaluation of 2-alkylaminoethyl-1,1- bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii targeting farnesyl diphosphate synthase (2008) Bioorganic and Medicinal Chemistry, 16 (6), pp. 3283-3290. , DOI 10.1016/j.bmc.2007.12.010, PII S0968089607010607
• Szajnman, S.H., Ravaschino, E.L., Docampo, R., Rodriguez, J.B., Synthesis and biological evaluation of 1-amino-1,1-bisphosphonates derived from fatty acids against Trypanosoma cruzi targeting farnesyl pyrophosphate synthase (2005) Bioorg. Med. Chem. Lett., 15, pp. 4685-4690
• Szajnman, S.H., Montalvetti, A., Wang, Y., Docampo, R., Rodriguez, J.B., Bisphosphonates derived from fatty acids are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase (2003) Bioorganic and Medicinal Chemistry Letters, 13 (19), pp. 3231-3235. , DOI 10.1016/S0960-894X(03)00663-2
• Szajnman, S.H., Bailey, B.N., Docampo, R., Rodriguez, J.B., Bisphosphonates derived from fatty acids are potent growth inhibitors of Trypanosoma cruzi (2001) Bioorg. Med. Chem. Lett., 11, pp. 789-792
• Urbina, J.A., Specific chemotherapy of Chagas disease: Relevance, current limitations and new approaches (2010) Acta Trop., 115, pp. 55-68
• Urbina, J.A., New insights in Chagas' disease treatment (2010) Drugs Fut., 35, pp. 409-420
• Urbina, J.A., Trypanosoma cruzi contains major pyrophosphate stores, and its growth in vitro and in vivo is blocked by pyrophosphate analogs (1999) J. Biol. Chem., 274, pp. 33609-33615
• Urbina, J.A., Docampo, R., Specific chemotherapy of Chagas disease: Controversies and advances (2003) Trends in Parasitology, 19 (11), pp. 495-501. , DOI 10.1016/j.pt.2003.09.001
• Yardley, V., In vivo activities of farnesyl pyrophosphate synthase inhibitors against Leishmania donovani and Toxoplasma gondii (2002) Antimicrob. Agents Chemother., 46, pp. 929-931

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------